BRRND · Bryn Inc.
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$9.45M
Shares
4,500
Volume
—
Avg daily vol (3M)
—
No Price Data
No daily price data is available for this stock yet. Data syncs automatically.
Up next
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Limited
Market backdrop
VIX 14.8 · calm
Equity put/call 0.56
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRRND
this stock
Bryn Inc.
|
$9.45M | — | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$52.05B | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$649.10M | +2.9% | — | — | 0.2% |
|
CCXI
Churchill Capital Corp XI
|
$608.80M | — | — | — | 5.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Key facts
CIK
1397795